Mirzai, Saeid
Sandesara, Uttsav
Haykowsky, Mark J.
Brubaker, Peter H.
Kitzman, Dalane W.
Peters, Anthony E.
Funding for this research was provided by:
Wake Forest University
Article History
Accepted: 6 May 2025
First Online: 15 May 2025
Declarations
:
: SM and US are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (T32-HL-076132). PHB has received honoraria as a consultant for Boston Scientific, Boehringer Ingelheim, Corvia Medical, and Merck. DWK has received honoraria as a consultant for Bayer, Medtronic, Relypsa, Merck, Corvia Medical, Boehringer Ingelheim, Ketyo, Rivus, NovoNordisk, AstraZeneca‚ and Novartis; grant funding from Novartis, Bayer, NovoNordisk‚ and AstraZeneca; and has stock ownership in Gilead Sciences. AEP has received honoraria from Cytokinetics; and has had stock ownership in Bristol Myers Squibb. All other authors report no disclosures.
: The authors declare no competing interests.